Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation (CENTRAL)
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation (CENTRAL): an Investigator-initiated, Multicenter Real-world Study
Sponsor: 521 Hospital of NORINCO Group
This observational or N/A phase trial investigates Acute Cerebrovascular Disease and Arrhythmia and is currently actively recruiting participants. 521 Hospital of NORINCO Group leads this study, which shows 6 recorded versions since 2025 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
May 2024 — Jul 2024 [monthly]
Not Yet Recruiting
Status: Recruiting → Not Yet Recruiting
-
Jun 2023 — May 2024 [monthly]
Recruiting
-
Mar 2023 — Jun 2023 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Feb 2023 — Mar 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- 521 Hospital of NORINCO Group
- Ankang Central Hospital
- Baoji Central Hospital
- Chinese Academy of Medical Sciences, Fuwai Hospital
- First Affiliated Hospital Xi'an Jiaotong University
- Fu Wai Hospital, Beijing, China
- Fuwai Yunnan Cardiovascular Hospital
- Luoyang Central Hospital
- Shaanxi Provincial People's Hospital
- Tianjin Medical University Second Hospital
- Xiangyang Central Hospital
For direct contact, visit the study record on ClinicalTrials.gov .